103 related articles for article (PubMed ID: 25673160)
41. Identification of PFTAIRE protein kinase 1, a novel cell division cycle-2 related gene, in the motile phenotype of hepatocellular carcinoma cells.
Pang EY; Bai AH; To KF; Sy SM; Wong NL; Lai PB; Squire JA; Wong N
Hepatology; 2007 Aug; 46(2):436-45. PubMed ID: 17559150
[TBL] [Abstract][Full Text] [Related]
42. Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines.
Lirdprapamongkol K; Chiablaem K; Sila-Asna M; Surarit R; Bunyaratvej A; Svasti J
Biochem Biophys Res Commun; 2012 Jun; 422(3):429-35. PubMed ID: 22580004
[TBL] [Abstract][Full Text] [Related]
43. A homeobox protein, prox1, is involved in the differentiation, proliferation, and prognosis in hepatocellular carcinoma.
Shimoda M; Takahashi M; Yoshimoto T; Kono T; Ikai I; Kubo H
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6005-11. PubMed ID: 17062673
[TBL] [Abstract][Full Text] [Related]
44. miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.
Du JY; Wang LF; Wang Q; Yu LD
Oncol Rep; 2015 Apr; 33(4):1890-8. PubMed ID: 25672572
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma.
Lai KP; Chen J; He M; Ching AK; Lau C; Lai PB; To KF; Wong N
Int J Cancer; 2014 Oct; 135(8):1790-9. PubMed ID: 24585547
[TBL] [Abstract][Full Text] [Related]
46. The significance of fibroblast growth factor receptor 2 expression in differentiation of hepatocellular carcinoma.
Harimoto N; Taguchi K; Shirabe K; Adachi E; Sakaguchi Y; Toh Y; Okamura T; Kayashima H; Taketomi A; Maehara Y
Oncology; 2010; 78(5-6):361-8. PubMed ID: 20798558
[TBL] [Abstract][Full Text] [Related]
47. Gene expression associated with the decrease in malignant phenotype of human liver cancer cells following stimulation with a histone deacetylase inhibitor.
Wakabayashi K; Saito H; Kaneko F; Nakamoto N; Tada S; Hibi T
Int J Oncol; 2005 Jan; 26(1):233-9. PubMed ID: 15586245
[TBL] [Abstract][Full Text] [Related]
48. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
[TBL] [Abstract][Full Text] [Related]
49. Biological function of a novel gene overexpressed in human hepatocellular carcinoma.
Liu J; Zhou R; Zhang N; Rui J; Jin C
Chin Med J (Engl); 2000 Oct; 113(10):881-5. PubMed ID: 11775832
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.
Zhang SH; Qian YM; Liu AW; Cai J; Zhao XL; Wei JJ; Zhu MH
Hum Pathol; 2012 Jul; 43(7):1084-93. PubMed ID: 22204716
[TBL] [Abstract][Full Text] [Related]
51. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma.
Li XM; Tang ZY; Zhou G; Lui YK; Ye SL
J Exp Clin Cancer Res; 1998 Mar; 17(1):13-7. PubMed ID: 9646228
[TBL] [Abstract][Full Text] [Related]
52. HoxB3 promotes prostate cancer cell progression by transactivating CDCA3.
Chen J; Zhu S; Jiang N; Shang Z; Quan C; Niu Y
Cancer Lett; 2013 Apr; 330(2):217-24. PubMed ID: 23219899
[TBL] [Abstract][Full Text] [Related]
53. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.
Park JR; Kim RJ; Lee YK; Kim SR; Roh KJ; Oh SH; Kong G; Kang KS; Nam JS
J Hepatol; 2011 Jan; 54(1):122-31. PubMed ID: 20952084
[TBL] [Abstract][Full Text] [Related]
54. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Wang Z; Wei W; Sun CK; Chua MS; So S
Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
[TBL] [Abstract][Full Text] [Related]
55. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.
Tsai WC; Hsu PW; Lai TC; Chau GY; Lin CW; Chen CM; Lin CD; Liao YL; Wang JL; Chau YP; Hsu MT; Hsiao M; Huang HD; Tsou AP
Hepatology; 2009 May; 49(5):1571-82. PubMed ID: 19296470
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
58. HCMDB: the human cancer metastasis database.
Zheng G; Ma Y; Zou Y; Yin A; Li W; Dong D
Nucleic Acids Res; 2018 Jan; 46(D1):D950-D955. PubMed ID: 29088455
[TBL] [Abstract][Full Text] [Related]
59. Immunohistochemistry Study of OY-TES-1 Location in Fetal and Adult Human Tissues.
Fu J; Yingying Ge ; Qingmei Zhang ; Lin Y; Liu C; Nong W; Luo X; Xiao S; Xie X; Luo B
J Healthc Eng; 2022; 2022():7052830. PubMed ID: 35463688
[TBL] [Abstract][Full Text] [Related]
60. Analysis of the mechanisms mediating tumor-specific changes in gene expression in human liver tumors.
Acevedo LG; Bieda M; Green R; Farnham PJ
Cancer Res; 2008 Apr; 68(8):2641-51. PubMed ID: 18413731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]